Buy ARA-290 Peptide in Australia

Buy ARA-290 in Australia from Macropus Peptides as a research-grade peptide in a sealed 10mg vial. Also known as cibinetide, it is an 11 amino acid peptide modelled on a small region of erythropoietin, designed to activate the body's tissue-protective innate repair receptor without stimulating red blood cell production. It has been studied in animal models of tissue injury and in clinical trials of small fibre neuropathy, and remains an investigational compound. Each vial holds lyophilised powder under a sealed closure, labelled with compound, strength, lot number and storage temperature, and every lot has its own certificate of analysis. The 10mg vial is currently supplied on quote: send us the quantity you need and we will confirm pricing. Order ARA-290 online with bacteriostatic water for reconstitution, and the parcel ships from Australian stock to any address in the country. Sold to researchers aged 18 and over, strictly for in-vitro laboratory research and not for human or veterinary use.

Compound	ARA-290
Amount	10 mg
Form	Lyophilised powder
Category	Recovery research
Storage	-20 °C, protect from light
Testing	HPLC purity and mass spectrometry identity, every batch
Certificate of analysis	Available for every lot, matched to the lot number on the label

ARA-290 10mg vial

Enter the diluent volume added to this vial to see the solution concentration. Laboratory calculation only, not dosing guidance.

Diluent added (mL)

Buy ARA-290 Australia: 10mg Research Peptide Vial

Macropus Peptides supplies ARA-290 to Australian laboratories as a research-grade peptide in a single 10mg vial. It belongs to a small group of peptides designed to separate the protective effects of a natural hormone from its other actions, and we list it in our recovery research range beside related tissue repair compounds. The vial is supplied on quote, lot-released and dispatched from our Australian shelves.

What is ARA-290

ARA-290, also called cibinetide, is a synthetic peptide of 11 amino acids. Its sequence copies a short stretch of helix B, one of the four helices that make up erythropoietin, the kidney hormone that drives red blood cell production. That region faces away from the part of erythropoietin that stimulates blood cell formation, which is why a peptide built from it keeps the hormone's tissue-protective signalling while leaving blood production untouched. The first residue is a pyroglutamate, and in the scientific literature the peptide is often called pyroglutamate helix B surface peptide. It was developed by a US biotechnology company and has been through clinical trials, but it is not approved as a medicine anywhere.

How the ARA-290 peptide works in research

Erythropoietin acts through two different receptor arrangements. The classic one, a pair of erythropoietin receptors, drives red blood cell production. The second combines one erythropoietin receptor with the beta common receptor, also known as CD131, and is called the innate repair receptor because it switches on protective, anti-inflammatory signalling when tissue is stressed or injured. This peptide was designed to activate only that second receptor. In laboratory and animal studies that activity has been linked to reduced inflammatory signalling and preserved tissue after injury, and researchers use it to study nerve, kidney and heart injury models without the confounding effect of rising red cell counts.

ARA-290 research: what the studies show

Two PNAS papers frame the research. The first, in 2004, described how erythropoietin protects tissue through a heteroreceptor built from the erythropoietin receptor and the beta common subunit. The second, in 2008, showed that small peptides taken from the tertiary structure of erythropoietin could be tissue-protective without stimulating red cell production, the design principle behind this compound. Clinical work followed, with phase 2 trials in small fibre neuropathy linked to sarcoidosis and to type 2 diabetes. The published studies are listed in our ARA-290 research studies library, each linked to PubMed.

ARA-290 vial specifications

Inside each vial is a freeze-dried white cake of peptide; the label records what it is, how much, which lot and how cold to keep it. The lot number ties the vial to its batch certificate of analysis, issued on request. Keep sealed vials frozen at -20 °C and away from light, and once the powder has been dissolved, keep the dissolved peptide chilled and out of the freezer.

ARA-290 price in Australia

The 10mg vial is supplied on quote rather than at a listed price. Send us the number of vials you need and we will confirm pricing and availability for your lot before you commit, so larger orders can be planned on a single batch.

ARA-290 10mg: where to buy in Australia

The 10mg vial is the only size we supply, and it covers most in-vitro studies from one lot. Use 2 mL of bacteriostatic water for a working stock of 5 mg in each millilitre, or 5 mL if your assay runs at the weaker 2 mg per mL for protocols that work at lower concentrations. Because peptides of this size can be sensitive to handling, we recommend dividing the stock into single-use portions on the day it is mixed.

Best place to buy ARA-290 Australia

• Research-grade peptide in a sealed 10mg vial, quoted before you order
• Batch certificate available for every lot, matched to the label
• Held in Australia and posted from inside Australia, avoiding customs holds
• Related recovery peptides and diluents available in the same parcel
• Clear research-use terms and no human-use claims

How to buy ARA-290 online

• Send us a quote request with the number of 10mg vials you need
• Confirm the quoted price and lot availability
• Add bacteriostatic water to the order if you need a diluent
• Pay and confirm that the order is adult laboratory use
• Record the lot number when the parcel arrives and request its certificate

ARA-290 reconstitution: calculator and cloudy solutions

The concentration calculator in each listing converts any diluent volume into mg and mcg per mL for the 10mg vial. Most laboratories use bacteriostatic water, added slowly down the inside of the vial and swirled gently rather than shaken. A solution that turns cloudy usually points to agitation, too little diluent or a temperature shock from adding cold liquid to a warm vial; let the vial warm up on the bench first, and throw out anything with specks in it. The remaining diluents sit under lab supplies and kits.

Is ARA-290 available in Australia

Australian laboratories can order it as research material, the sole form we sell. Nothing containing it appears on the ARTG, which rules out supply for human or veterinary use. Scheduling decisions rest with the TGA and may shift, so check your organisation's obligations under the Poisons Standard first.

ARA-290 for sale Australia wide

Orders are packed at our Australian facility and posted to every state and territory. Researchers working on tissue protection and inflammation often compare this peptide with BPC-157, which is studied in tendon and gut repair models, and with KPV, a short anti-inflammatory tripeptide. Thymosin Alpha-1 and the rest of the recovery research range are listed alongside.

Questions about ARA-290 10mg